10-hydroxycamptothecin has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SS; Tang, YM; Xu, XJ; Yuan, ZF; Zhang, JY | 1 |
| Pan, BH; Shi, SW; Song, H; Tang, YM; Yang, SL; Yuan, ZF; Zhao, FY | 1 |
2 other study(ies) available for 10-hydroxycamptothecin and Neuroblastoma
| Article | Year |
|---|---|
10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspase 3; Cell Proliferation; Cytochromes c; Humans; Neuroblastoma; Tumor Suppressor Protein p53 | 2016 |
[Efficacy of chemotherapy using 10-hydroxycamptothecin on recurrent or refractory neuroblastoma in children].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Female; Humans; Male; Neuroblastoma; Recurrence | 2009 |